0001209191-20-045698.txt : 20200807
0001209191-20-045698.hdr.sgml : 20200807
20200807174133
ACCESSION NUMBER: 0001209191-20-045698
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200805
FILED AS OF DATE: 20200807
DATE AS OF CHANGE: 20200807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Suri Anish
CENTRAL INDEX KEY: 0001739130
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 201085637
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-05
0
0001645460
Cue Biopharma, Inc.
CUE
0001739130
Suri Anish
C/O CUE BIOPHARMA, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
0
1
0
0
President and CSO
Common Stock
2020-08-05
4
M
0
800
6.42
A
35358
D
Common Stock
2020-08-05
4
S
0
800
20.01
D
34558
D
Stock Option (right to buy)
6.42
2020-08-05
4
M
0
800
0.00
D
2029-03-06
Common Stock
800
145000
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020.
This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019.
/s/ Anish Suri by Mark Busch, attorney-in-fact
2020-08-07